TCVAX | VMVIX | TCVAX / VMVIX | |
Total Expense Ratio | 1.17 | 0.19 | 616% |
Annual Report Gross Expense Ratio | 1.39 | 0.19 | 732% |
Fund Existence | 16 years | 19 years | - |
Gain YTD | 2.502 | 3.338 | 75% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 554M | 31B | 2% |
Annual Yield % from dividends | 0.53 | 2.10 | 25% |
Returns for 1 year | 3.92 | 9.57 | 41% |
Returns for 3 years | 4.02 | 20.88 | 19% |
Returns for 5 years | 34.40 | 63.67 | 54% |
Returns for 10 years | 40.64 | 84.72 | 48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DMXF | 73.63 | 0.82 | +1.13% |
iShares ESG Advanced MSCI EAFE ETF | |||
MGRO | 32.04 | N/A | N/A |
VanEck Morningstar Wide Moat Growth ETF | |||
XHYI | 38.13 | -0.02 | -0.06% |
BondBloxx US High Yield Indstrl Sctr ETF | |||
RZV | 108.14 | -0.25 | -0.23% |
Invesco S&P SmallCap 600® Pure Value ETF | |||
VOT | 287.91 | -1.07 | -0.37% |
Vanguard Mid-Cap Growth ETF |